Suppression of adjuvant disease by bacterial extracellular products.

Por Quagliata, F, Taranta, A
Publicado em 1972

Suppression of adjuvant arthritis by a new cytotoxic compound, rubidomycin.

Por Quagliata, F, Sanders, P M, Gardner, D L
Publicado em 1969

Effect of thoracic duct drainage on the primary and secondary immune responses in rats: induction of immunological tolerance

Por Phillips, Mildred E., Quagliata, F., Thorbecke, G. Jeanette
Publicado em 1972

Studies on the control of antibody synthesis: III. Changes in heterogeneity of antibody affinity during the course of the immune response

Por Werblin, T. P., Kim, Young Tai, Quagliata, F., Siskind, G. W.
Publicado em 1973

Attempted Prevention of Arteriolar Lesions in Accelerated Rat Hypertension by Immunosuppression

Por Gardner, D. L., Quagliata, F., Drossman, M., Kalish, M., Schimmer, B.
Publicado em 1970

Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations.

Por Tung, R, Silber, R, Quagliata, F, Conklyn, M, Gottesman, J, Hirschhorn, R
Publicado em 1976

Immunosuppressive activity of BCG: effects of adjuvant disease, lymphocyte subpopulations, and homing of thoracic duct cells in rats.

Por Sutherland, R I, Spadaro-Antonelli, M A, Lawrence, V J, Quagliata, F
Publicado em 1979